A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy - Concepedia

Concepedia

Publication | Open Access

A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy

DOI Full Paper Access

103

Citations

26

References

2020

Year

Carine El Sissy, Amos Kirilovsky, Marc Van den Eynde, Ana-Maria Mușină, Maria-Gabriela Aniței, Alfredo Romero, Florence Marliot, Audelaure Junca, J. Doyen, Bernhard Mlecnik,

Clinical Cancer Research

Abstract

IS<sub>B</sub> predicts response to nT and survival in patients with LARC treated by surgery. Its usefulness in the selection of patients eligible for a Watch-and-Wait strategy is strongly suggested.

References

	Year	Citations

Page 1